Key Amphetamine Drugs Market Players:
- Takeda Pharmaceutical (Japan)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG (Switzerland)
- Teva Pharmaceuticals (Israel/U.S.)
- Johnson & Johnson (U.S.)
- NeuroCare Pharma (India)
- Sun Pharma (India)
- Viatris (U.S.)
- Amneal Pharmaceuticals (U.S.)
- Shionogi & Co., Ltd. (Japan)
- Lupin Pharmaceuticals (India)
- Alkem Laboratories (India)
- Celltrion Healthcare (South Korea)
- Servier Laboratories (France)
- Pfizer Inc. (U.S.)
- GSK plc (UK)
The global market is very competitive, with giants such as Takeda, Novartis, and Teva strutting on the stage. Growth in APAC, FDA ANDA approvals, and patent renewals are some of the strategic issues in question. South Korean and Indian players are ramping up the supply of low-level generics, with the U.S. market focusing more on extended-release and abuse-deterrent formulations. Hybrid treatment approaches are the direction to take in licensing, such as Takeda and the integration of digital therapy by Teva. Regional funding and public health reforms for mental health projects through countries such as Malaysia and Australia are helping to make the future market more fiercely competitive.
Here is a list of key players operating in the global market:
